Business
We are subject to competitive risks that are typical in our end markets, including technical obsolescence.
CTS CORP: Revenue grew 5.2% to $541M from $515M. Net income grew 17.7% to $65.32M from $55.47M. Free cash flow grew 8.5% to $86.37M from $79.6M. Operating margin expanded 144 bps to 15.27%. CTS CORP's principal statistical and annual-change screens add no overriding warning to the reported profit and cash-flow record.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 5.2% to $541M from $515MOK
- Profitability — Net income grew 17.7% to $65.32M from $55.47MOK
- Cash flow — Free cash flow grew 8.5% to $86.37M from $79.6MOK
- Margins — Operating margin expanded 144 bps to 15.27%OK
- Accounting — No overriding statistical warningNote
- Insiders — 0 purchases and 4 salesWatch
Where the revenue comes from
Fiscal 2025, as CTS CORP reports it. History and quarterly detail are in the app.
- Geographic Distribution$304.7M
Leadership changes
From CTS CORP's own filings, the day they're filed.
- Kieran O'Sullivan · Chief Executive Officer · departureeff. 2026-07-06
- Pratik Trivedi · Chief Operating Officer · appointmenteff. 2025-12-05
- Martin Baumeister · President · departureeff. 2025-11-21
Latest filings
- 8-K · Company announcement2026-07-28
- 8-K · Company announcement2026-07-28
- 10-Q · Quarterly report2026-07-28
- 8-K · Company announcement2026-06-25
- 8-K · Company announcement2026-05-19
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CTS CORP, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.